About USGI Medical
USGI Medical is committed to the development of technologies that enable incisionless procedures which help patients return to normal activities and lifestyles faster compared to traditional laparoscopic and open surgery.
Missing: USGI Medical's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: USGI Medical's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing USGI Medical
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
USGI Medical is included in 2 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
USGI Medical Patents
USGI Medical has filed 79 patents.
Digestive system, Digestive system surgery, Medical equipment, Surgical removal procedures, Endoscopy
Digestive system, Digestive system surgery, Medical equipment, Surgical removal procedures, Endoscopy
Latest USGI Medical News
Sep 22, 2022
Major players in the bariatric surgery devices market are Ethicon (Johnson & Johnson), Medtronic, Intuitive Surgical, ReShape Lifesciences, Aspire Bariatrics, Mediflex Surgical Products, Spatz FGIA, Cousin Biotech, Olympus Corporation of the Americas, GI Dynamics, USGI Medical, Asensus Surgical US Inc, and Smith & Nephew. September 22, 2022 10:58 ET Lyon, FRANCE New York, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Bariatric Surgery Devices Global Market Report 2022" - https://www.reportlinker.com/p06317010/?utm_source=GNW The global bariatric surgery devices market is expected to grow from $1.59 billion in 2021 to $1.71 billion in 2022 at a compound annual growth rate (CAGR) of 8.06%. The bariatric surgery devices market is expected to grow to $2.26 billion in 2026 at a compound annual growth rate (CAGR) of 7.15%. The bariatric surgery devices market consists of sales of bariatric surgery devices by entities (organizations, sole traders, and partnerships) that refer to surgical devices used in bariatric surgery to reduce the weight of an individual by reducing the size of the stomach. Bariatric surgery devices are FDA-approved surgical equipment or devices used for surgeries performed in the gastrointestinal tract for facilitating weight loss for individuals with obesity or severe obesity. The main types of bariatric surgery devices include minimally invasive surgical devices, stapling devices, energy/vessel sealing devices, suturing devices, accessories, and non-invasive surgical devices.Minimally invasive surgical devices refer to surgical instruments specifically designed to perform the procedure through a small incision in the body rather than a large opening that benefits patients including reduced blood loss, minimal tissue damage, and faster recovery and rehabilitation time. These surgical devices are used in various procedures ranging from sleeve gastrectomy, gastric bypass, revision bariatric surgery, non-invasive bariatric surgery, adjustable gastric banding, mini-gastric bypass, and biliopancreatic diversion with duodenal switch. These surgical devices are widely used by clinics, hospitals, specialty centers, and ambulatory surgical centers. North America was the largest region in the bariatric surgery devices market in 2021.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bariatric surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The bariatric surgery devices market research report is one of a series of new reports that provides bariatric surgery devices market statistics, including bariatric surgery devices industry global market size, regional shares, competitors with a bariatric surgery devices market share, detailed bariatric surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the bariatric surgery devices industry. This bariatric surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The growing obese population is significantly contributing to the growth of the bariatric surgery devices market.Obesity refers to the abnormal or excessive accumulation of fat, which might impair the health of individuals. In recent years, obesity has become a public health challenge across the globe, with a substantial contribution to global mortality and morbidity.The growing utilization of surgical procedures by obesity population across the globe to mitigate fat deposits are expected to boost demand for bariatric surgery devices. For instance, according to the World Health Organization (WHO), over 1 billion people globally are obese currently (2022), out of which 650 million accounts for adults, 340 million are adolescents and 39 million are children. Therefore, an increase in the obese population will contribute to the growth of the bariatric surgery devices market. Technological advancement is a key trend gaining popularity in the bariatric surgery devices market.Key players operating in the bariatric surgery devices market are focusing on developing technologically advanced products to meet the surgical demands and strengthen their position in the market. These developments include devices that offer improved features for better outcomes in bariatric surgery while reducing risks during the procedure.For instance, in September 2021, Olympus Corporation, a Japan-based medical technology company launched POWERSEAL advanced bipolar surgical energy devices. POWERSEAL provides surgeons with state-of-the-art sealing, dissection, and grasping capabilities in laparoscopic or open surgery while highly reducing the force required by the surgeon to close the jaws. It can be used in various forms of surgical procedures including bariatric surgery, general surgery and gynaecological, colorectal, urological, and other surgeries. In February 2020, Medtronic plc, an American medical device company acquired Digital Surgery for an undisclosed amount.The acquisition by Medtronic focused on utilizing the in-house team of digital surgery for the development of pedestal-based robot surgery systems, which can be used in general, urology, gynaecology, thoracic, colorectal, and bariatric procedures. Digital Surgery, is a UK-based developer of digital surgical tools utilizing advanced technologies such as next-generation computing, AI, visualization, and other tools. The countries covered in the bariatric surgery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
USGI Medical Frequently Asked Questions (FAQ)
When was USGI Medical founded?
USGI Medical was founded in 2001.
Where is USGI Medical's headquarters?
USGI Medical's headquarters is located at 1140 Calle Cordillera, San Clemente.
What is USGI Medical's latest funding round?
USGI Medical's latest funding round is Loan.
How much did USGI Medical raise?
USGI Medical raised a total of $54.87M.
Who are the investors of USGI Medical?
Investors of USGI Medical include Paycheck Protection Program, Alta Partners, East West Bank, GE Capital, Healthcare Financial Services and 4 more.
Who are USGI Medical's competitors?
Competitors of USGI Medical include Clearflow, HydroCision, Dune Medical Devices, Spinal Kinetics, Entellus Medical and 13 more.
Compare USGI Medical to Competitors
Rhytec offers skin regeneration in dermatological surgery
Spectrum Medical is a manufacturer of oxygen saturation devices that are used in ECMO and Open Heart Surgery. Spectrum Medical supplies Clinical Information Solutions that include Medical Device Connectivity Technologies, Electronic Medical Record Systems, Telemedicine Capabilities and Compliance and Patient Safety Solutions. Spectrum Medical also supplies Non-invasive Diagnostics Systems for extracorporeal procedures. The company was founded in 2007 and is based in Gloucester, England.
HydroCision is a developer, manufacturer, and marketer of fluid-jet based surgical tools for the spine market. Incorporated in 1994, HydroCision's fluidjet technology is the basis of a new surgical modality leveraging compelling features and offering application versatility. The company is developing a broad range of fluidjet-based products to meet the needs of spine specialists.
BioSpiral's state-of-art system aims to provide prostate cancer treatment as a minimally invasive procedure, which uses cooling & heating technologies to destroy prostate cancer.nBioSpiral was established in Sep 2006 and is operating as part of NGT Incubator. nBioSpiral prostate thermodynamics therapy is an effective, minimally invasive treatment for prostate cancer that does not involve the difficulty and complications associated with surgery, nor the harmful properties of radiation or cryotherapy .The system revolutionizes prostate cancer treatment by introducing a "one shot" treatment method under local anesthesia at the physician's clinic. BioSpiral treatment is for patients with localized prostate cancer, who look for an effective minimal invasive therapy for prostate cancer. Additionally, this treatment can also be used by patients who have local recurrence after other treatments ("salvage" treatment). Key advantages:nCost effective: short treatment, no need for O.R or hospitalizationnHighly efficient: tissue ablationnPatients: high quality of life; minimal side effects, minimal invasive, short treatment & recovery.
Softscope Medical Technologies is developing a medical technology designed to facilitate the performance of endoscopic procedures.
Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment. Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.